Common Warts Drug Pipeline Report 2022 Featuring Verrica Pharmaceuticals, X4 Pharmaceuticals, Phio Pharmaceuticals, Kino Pharma, & NIELSEN BioSciences – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Common Warts – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This ”Common Warts – Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Common Warts pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … [Read more…]

New Rheumatology Research Foundation Award Focuses on Research Conducted in the Clinical Practice Setting

Community Practice Innovation Award to Help Advance Patient Care and Improve Patient Health ATLANTA–(BUSINESS WIRE)–The Rheumatology Research Foundation today announced the launch of a new grant, the Community Practice Innovation (CPI) Award. The grants will empower rheumatology practitioners to generate new research that advances patient care and improves the health of those living with rheumatic … [Read more…]

Iowa Board of Pharmacy Partners with Bamboo Health to Integrate Prescription Monitoring Data into Healthcare Prescribers and Dispensers’ Electronic Workflows

LOUISVILLE, Ky.–(BUSINESS WIRE)–Bamboo Health™, formerly Appriss Health and PatientPing, a healthcare technology solutions company focused on fostering care collaboration and providing information and actionable insights across the entire continuum of care today announced its expanded partnership with the Iowa Board of Pharmacy to offer Prescription Monitoring Program (PMP) integration within Iowa providers’ electronic health record … [Read more…]

Kaia Health Reduces Back Pain by 46% in Rise-uP Randomized Controlled Trial Results

Digital therapeutic delivers gold-standard treatment for nonspecific back pain, improves function and quality of life outcomes. Kaia Health users experienced pain reduction of 1.85 points after only 3 months Cost-effectiveness analysis shows a reduction in healthcare costs of up to 80% versus traditional care Federal Joint Committee (G-BA),3 has recommended applying the approach of Rise-uP … [Read more…]

Navitus Health Solutions Selected by Health Transformation Alliance as Pharmacy Benefit Manager Partner

MADISON, Wis.–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, announced today that it has been selected as a partner by the Health Transformation Alliance (HTA) to provide best-in-class PBM services for its members. Through this partnership, Navitus will offer … [Read more…]

LG Chem Enters Final Stage of Clinical Development for New Gout Drug

SEOUL, South Korea & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#Gout–LG Chem recently announced that the Company has submitted an IND application to the US FDA for its first independent global Phase 3 clinical trial of its new gout drug ‘Tigulixostat’ (clinical program name: EURELIA_1 Study). LG Chem’s strategy is to expand its life sciences business and to reach … [Read more…]

Model N and Pfizer Innovate Drug Price Transparency Reporting

NEW ‘Transparency Talks’ With Pfizer and Global Pricing Innovations (GPI) Help Pharmaceutical Companies Stay Compliant With Drug Pricing SAN MATEO, Calif.–(BUSINESS WIRE)–#LifeSciences—Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance, today announced the launch of Transparency Talks, a new, three-part education series for pharmaceutical companies that tackles the topic of price transparency … [Read more…]

Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange

SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (OTCQB: KNWN) an emerging developer of non-invasive medical diagnostic technology, today announced it has filed a Form S-1 registration statement for a proposed new offering of 3 million shares of its common stock with an anticipated offering price of $2.00 per share. Concurrent with, and as a condition to, the offering, … [Read more…]

Kelly Roland Promoted to President of Texas Original

AUSTIN, Texas–(BUSINESS WIRE)–Texas Original, Texas’ leading medical cannabis provider, announced that Kelly Roland has been promoted to president. Roland served as Texas Original’s senior vice president of sales and chief revenue officer for three years. During that time, she oversaw and drove the company’s rise to its commanding leadership position in Texas’ growing cannabis market. … [Read more…]